These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17936641)

  • 21. Toward optimal health: managing women's medical challenges in midlife.
    Godfrey JR; Naftolin F
    J Womens Health (Larchmt); 2008 Dec; 17(10):1551-4. PubMed ID: 19000032
    [No Abstract]   [Full Text] [Related]  

  • 22. A reader and author respond to "Who best cares for the postmenopausal woman's comprehensive medical and health needs?".
    Birmingham LF
    MedGenMed; 2007 Oct; 9(4):4; author reply 4. PubMed ID: 18311354
    [No Abstract]   [Full Text] [Related]  

  • 23. Commentary: What's the deal with menopause management? Why the Women's Health Initiative raises more questions than it answers.
    Richardson MK
    Postgrad Med; 2005 Aug; 118(2):21-6. PubMed ID: 16164102
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.
    Modena MG; Bursi F; Fantini G; Cagnacci A; Carbonieri A; Fortuna A; Rossi R
    Am J Med; 2002 Sep; 113(4):331-4. PubMed ID: 12361820
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormones and bone health in postmenopausal women.
    Lindsay R
    Endocrine; 2004 Aug; 24(3):223-30. PubMed ID: 15542889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What pharmacists need to know about the women's health initiative estrogen plus progestin trial.
    Saseen JJ; Hansen LB
    Am J Health Syst Pharm; 2003 Feb; 60(3):281-4. PubMed ID: 12613239
    [No Abstract]   [Full Text] [Related]  

  • 27. Trends of determinants of hormone therapy use in Italian women attending menopause clinics, 1997-2003.
    Parazzini F;
    Menopause; 2008; 15(1):164-70. PubMed ID: 17581495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes of Korean clinicians to postmenopausal hormone therapy after the Women's Health Initiative study.
    Kang BM; Kim MR; Park HM; Yoon BK; Lee BS; Chung HW; Cho SH; Choi H; Kim JG
    Menopause; 2006; 13(1):125-9. PubMed ID: 16607108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women and public health emergency preparedness.
    Katz R; Mauery DR
    Womens Health Issues; 2010; 20(1):3-6. PubMed ID: 20123170
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute effect of estrogen on metabolic coronary vasodilator responses to atrial pacing in postmenopausal women.
    Anderson TJ
    Am J Cardiol; 1998 Jul; 82(2):236-9. PubMed ID: 9678297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re.: Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative Hormone Therapy Trials.
    Assimos D
    J Urol; 2011 May; 185(5):1749-50. PubMed ID: 22088708
    [No Abstract]   [Full Text] [Related]  

  • 32. American Medical Women's Association position paper on sex- and gender-specific medicine.
    Werbinski J
    J Womens Health (Larchmt); 2008 Dec; 17(10):1557. PubMed ID: 19000030
    [No Abstract]   [Full Text] [Related]  

  • 33. Timing of hormone therapy influences breast cancer risk.
    Harv Womens Health Watch; 2011 Apr; 18(8):7. PubMed ID: 21544975
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of mastodynia in postmenopausal women taking hormone therapy.
    Carranza-Lira S; Garduño-Hernández MP; Caisapanta DA; Aparicio H
    Int J Gynaecol Obstet; 2005 May; 89(2):158-9. PubMed ID: 15847887
    [No Abstract]   [Full Text] [Related]  

  • 36. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Good science or good marketing?
    Head K
    Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
    [No Abstract]   [Full Text] [Related]  

  • 38. The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.
    Blake JM; Collins JA; Reid RL; Fedorkow DM; Lalonde AB; Christilaw J; Fortier M; Fortin C; Jolly EE; Lemay A; O'Grady T; Smith TE; Cooper J; Maxted JM; O'Grady K; Turek MA;
    J Obstet Gynaecol Can; 2002 Oct; 24(10):783-90, 793-802. PubMed ID: 12399806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal health: a reassessment post WHI.
    Rees MC
    Int J Fertil Womens Med; 2003; 48(2):55-6. PubMed ID: 12779290
    [No Abstract]   [Full Text] [Related]  

  • 40. Women and heart disease: neglected directions for future research.
    Barrett-Connor E
    J Cardiovasc Transl Res; 2009 Sep; 2(3):256-7. PubMed ID: 19654884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.